Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial

Autor: Russell-Jones, David *, Babazono, Tetsuya, Cailleteau, Roman, Engberg, Susanne, Irace, Concetta, Kjaersgaard, Maiken Ina Siegismund, Mathieu, Chantal, Rosenstock, Julio, Woo, Vincent, Klonoff, David C
Zdroj: In The Lancet 4-10 November 2023 402(10413):1636-1647
Databáze: ScienceDirect